Buy Merus Stock | MRUS Stock Price & Latest News | Public.com
MRUS

Merus

$0.00 (0.00%)Today
    View Merus (MRUS) stock trends here

    About MRUS

    Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.36
    -0.71
    -1.07
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.62

    Actual EPS
    Q2 2021

    Stats

    Market Cap$864.4M
    Volume243.29k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$31.27
    1 Year Low$10.18
    Open$22.99
    High$26.12
    Low$22.79

    Buy any stock with any amount of money.

    Download the App
    Download the app